Literature DB >> 3013003

Ig gamma restriction fragment length polymorphisms indicate an ancient separation of Caucasian haplotypes.

M J Johnson, G de Lange, L L Cavalli-Sforza.   

Abstract

This investigation was undertaken to study genetic variation in the human immunoglobulin gamma heavy-chain (IgG) genes using Southern blot hybridization techniques to identify restriction fragment length polymorphisms (RFLPs). A genomic Ig gamma-1 clone was used as a probe, and variants were identified with two restriction enzymes (R.E.), each of which defined RFLPs at two separate IgG loci. Once alleles and haplotypes were determined, molecular localization of the alleles was made through genetic analysis of recombinant haplotypes and through the use of regional specific subclones. Linkage between the newly defined RFLPs and switch region variants as well as protein allotypic markers (Gm) was complete. This analysis included markers for Ig Mu, Alpha 1, Alpha 2, Gamma 1, Gamma 2, Gamma 3, and Pseudo Gamma. The picture that emerges from the molecular study of two common haplotypes, each with many rare variants resulting from recombination or mutation, confirms and extends the earlier immunological observations. The accumulated differences between the two major Caucasian IgG haplotypes indicate that their separation may be ancient and maintained through heterozygote advantage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013003      PMCID: PMC1684818     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Selection for heterozygotes in small populations.

Authors:  A ROBERTSON
Journal:  Genetics       Date:  1962-09       Impact factor: 4.562

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Nucleotide sequence of a human immunoglobulin C gamma 4 gene.

Authors:  J Ellison; J Buxbaum; L Hood
Journal:  DNA       Date:  1981

5.  Linkage and sequence homology of two human immunoglobulin gamma heavy chain constant region genes.

Authors:  J Ellison; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Structure of human immunoglobulin gamma genes: implications for evolution of a gene family.

Authors:  N Takahashi; S Ueda; M Obata; T Nikaido; S Nakai; T Honjo
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

7.  Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes.

Authors:  J G Flanagan; T H Rabbitts
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

8.  Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals.

Authors:  M P Lefranc; G Lefranc; T H Rabbitts
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

9.  Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man.

Authors:  N Migone; J Feder; H Cann; B van West; J Hwang; N Takahashi; T Honjo; A Piazza; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Prenatal diagnosis using DNA polymorphisms. Report on 95 pregnancies at risk for sickle-cell disease or beta-thalassemia.

Authors:  C D Boehm; S E Antonarakis; J A Phillips; G Stetten; H H Kazazian
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

View more
  12 in total

1.  Multiple levels of analysis of an IGHG4 gene deletion.

Authors:  A Bottaro; U Cariota; G G de Lange; M DeMarchi; R Gallina; S Oliviero; A Vlug; A O Carbonara
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

Review 2.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Complete physical map of the human immunoglobulin heavy chain constant region gene complex.

Authors:  M H Hofker; M A Walter; D W Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Gm typing by immunoglobulin heavy-chain gene RFLP analysis.

Authors:  E C Jazwinska; H Dunckley; D N Propert; P A Gatenby; S W Serjeantson
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

5.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  A deductive method of haplotype analysis in pedigrees.

Authors:  E M Wijsman
Journal:  Am J Hum Genet       Date:  1987-09       Impact factor: 11.025

7.  Nonrandom allele associations between unlinked protein loci: are the polymorphisms of the immunoglobulin constant regions adaptive?

Authors:  W van der Loo; C P Arthur; B J Richardson; M Wallage-Drees; R Hamers
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Polymorphisms of the immunoglobulin heavy-chain delta gene and association with other constant-region genes.

Authors:  J C Benger; D W Cox
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  IgH (mu-switch and gamma-1) region restriction fragment length polymorphism in human narcolepsy.

Authors:  S M Singh; C F George; R N Ott; C Rattazzi; C Guilleminault; W C Dement; E Mignot
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

10.  Nonuniform linkage disequilibrium within a 1,500-kb region of the human immunoglobulin heavy-chain complex.

Authors:  M A Walter; D W Cox
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.